首页> 外文期刊>European journal of emergency medicine: Official journal of the European Society for Emergency Medicine >beta-Blockers versus calcium channel blockers for acute rate control of atrial fibrillation with rapid ventricular response: a systematic review
【24h】

beta-Blockers versus calcium channel blockers for acute rate control of atrial fibrillation with rapid ventricular response: a systematic review

机译:β受体阻滞剂与钙通道阻滞剂联用可快速控制心室纤颤并快速反应室速:系统评价

获取原文
获取原文并翻译 | 示例
           

摘要

This is a systematic review of the literature to compare the efficacy of calcium channel blockers to beta-blockers for acute rate control of atrial fibrillation with rapid ventricular response in the emergency department setting. PubMed, EMBASE, and the Cochrane Registry were searched. Relative risk (95% confidence interval) was calculated between drugs and methodological quality of included studies was evaluated. Of the 1003 studies yielded by our initial search, two met inclusion criteria and provided sufficient data. These were randomized double-blinded studies (n=92) comparing intravenous diltiazem with intravenous metoprolol. The combined relative risk of acute rate control by diltiazem versus metoprolol was 1.8 (95% confidence interval 1.2-2.6). On the basis of the paucity of available evidence, diltiazem may be more effective than metoprolol in achieving rapid rate control, but high-quality randomized studies are needed. Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.
机译:这是一篇系统的文献综述,比较了急诊科室中钙通道阻滞剂与β受体阻滞剂在快速控制心室纤颤和快速心室反应方面的疗效。搜索PubMed,EMBASE和Cochrane注册表。计算药物之间的相对风险(95%置信区间),并评估纳入研究的方法学质量。我们的初步搜索产生了1003项研究,其中两项符合纳入标准并提供了足够的数据。这些是随机双盲研究(n = 92),比较了地尔硫卓和静脉注射美托洛尔。地尔硫卓与美托洛尔联合控制急性发生率的相对危险度为1.8(95%置信区间1.2-2.6)。由于缺乏可用证据,地尔硫卓在控制心律失常方面可能比美托洛尔更有效,但仍需要高质量的随机研究。版权所有(C)2015 Wolters Kluwer Health,Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号